OTC Markets Group Inc. (OTCQX:OTCM) has announced that Sandoz Group AG, a global leader in generic pharmaceuticals and biosimilars, has qualified to trade on the OTCQX Best Market.
Sandoz, a spin-off of Novartis AG (ADR) (NYSE:NVS), will trade under the symbols 'SDZNY' and 'SDZXF.'
“As an independent company, Sandoz will be fully enabled to deliver on its purpose-driven strategy, which targets sustainable leadership in the growing and critical generics and biosimilars industry," CEO Richard Saynor commented.